Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

14:00, 9 July 2024 JDoerfler talk contribs created page Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial }} {{Study Note}} =Brief summary= This study investigated the efficacy of vitamin E in colorectal cancer patients to alleviate chemotherapy-associated peripheral neuropathy (i.e. damage to several peripheral nerves). The intervention arm took additional vitamin E during chemotherapy and the control arm received only a placebo. The...")
13:50, 9 July 2024 JDoerfler talk contribs created page Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Publication |Title=Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial |Topic=Vitamin E |Author=Salehi, Z; Roayaei M |Year=2015 |Journal=International Journal of preventive Medicine |DOI=https://doi.org/10.4103/2008-7802.169021 |Authors Abstract=Background: Peripheral neuropathy is one of the most important limitations of oxaliplatin base regimen, which is the standard for the treatment of colorectal cancer. Eviden...")
13:09, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2010): Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection for cisplatin neuropathy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instead. The results of this study are analogous to th...")
13:06, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Publication |Title=Vitamin E neuroprotection for cisplatin neuropathy |Topic=Vitamin E |Author=Pace, A; Giannarelli, D; Galie, E; Savarese, A; Carpano, S; Della Giulia, M; Pozzi, A; Silvani, A; Gaviani, P; Scaioli, V; Jandolo, B; Bove, L; Cognetti, F |Year=2010 |Journal=Neurology |DOI=https://doi.org/10.1212/WNL.0b013e3181d5279e |Authors Abstract=The clinical use of platinum-based antineoplastic agents is limited by severe peripheral neurotoxicity reported in up to 90%...")
12:06, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Reference |Reference=Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instea...")
12:02, 9 July 2024 JDoerfler talk contribs created page Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Publication |Title=Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy |Topic=Vitamin E |Author=Pace, A; Savarese, A; Picardo, M; Maresca, V; Pacetti, U; Del Monte, G; Biroccio, A; Leonetti, C; Jandolo, B; Cognetti, F; Bove, L |Year=2003 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2003.05.139 |Authors Abstract=Purpose: The aim of this study is to evaluate the neuroprotective effect of antioxidant...")
08:51, 9 July 2024 JDoerfler talk contribs deleted page TestPublication (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
08:49, 9 July 2024 JDoerfler talk contribs moved page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. to Dale, PS without leaving a redirect
08:27, 9 July 2024 JDoerfler talk contribs created page Test author (Created blank page)
07:26, 9 July 2024 JDoerfler talk contribs created page Mondal et al. (2014): Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Reference |Reference=Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy }} {{Study Note}} =Brief summary= In this study, four different arms of cancer patients were examined, all of whom received chemotherapy. During chemotherapy, one arm received additional vitamin E, one arm vitamin B12, one arm glutamine and the last arm carnitine. Components of peripheral neuro...")
07:22, 9 July 2024 JDoerfler talk contribs created page Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Publication |Title=Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy |Topic=Vitamin E, Carnitine, Vitamin B12 |Author=Mondal, S; Choudhury, KB; Sharma, S; Gupta, A; Dutta, S |Year=2014 |Journal=Clinical Cancer Investigation Journal |DOI=https://doi.org/10.4103/2278-0513.132113 |Authors Abstract=Context One of the major toxicities of paclitaxel is peripheral neuropathy, primar...")
06:28, 9 July 2024 JDoerfler talk contribs created page Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial }} {{Study Note}} =Brief summary= In this study, bladder cancer patients were examined with regard to the occurrence of recurrences after surgery, with half of the patients taking vitamin E daily and the other half taking nothing. There were significantly fewer recurrences in the vitamin E arm (19% vs. 36%) than in the control arm. There were no diff...")
06:27, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Publication |Title=Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial |Topic=Vitamin E |Author=Mazdak, H; Zia, H |Year=2012 |Journal=International Journal of Preventive Medicine |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278875/ |Authors Abstract=Background Most patients with superficial bladder cancer who undergo transurethral resection of bladder tumor show recurrence of the disease. Numerous studies have explored ways to...")
12:11, 8 July 2024 JDoerfler talk contribs created page Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Reference |Reference=Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial }} {{Study Note}} =Brief summary= This study investigated the effectiveness of vitamin E in preventing chemotherapy-induced peripheral polyneuropathy. The vitamin E arm took vitamin E twice a day in parallel with chemotherapy until one month after chemotherapy, while the control arm received only a place...")
11:46, 8 July 2024 JDoerfler talk contribs created page Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Publication |Title=The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial |Topic=Vitamin E |Author=Kottschade, LA; Sloan, JA; Mazurczak, MA; Johnson, DB; Murphy, BP; Rowland, KM; Smith, DA; Berg, AR; Stella, PJ; Loprinzi, CL |Year=2011 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-010-1018-3 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CIPN) co...")
13:50, 5 July 2024 JDoerfler talk contribs created page Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Reference |Reference=Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation }} {{Study Note}} =Brief summary= In this study, various leukemia patients were divided into two different arms prior to bone marrow transplantation. One arm began taking vitamin E seven days before the operation until 28 days afterwards in addition to chemotherapy, while the other received only a placebo in...")
13:48, 5 July 2024 JDoerfler talk contribs created page Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Publication |Title=Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation |Topic=Vitamin E |Author=Ghoreishi, Z; Shidfar, F; Iravani, M; Esfahani, A; Ghavamzadeh, A |Year=2007 |Journal=Asia-Pacific Journal of Clinical Oncology |DOI=https://10.1111/j.1743-7563.2007.00111.x |Authors Abstract=Aim: This study was conducted to investigate the effect of oral vitamin E on mucositis and neutropenia in p...")
12:34, 5 July 2024 JDoerfler talk contribs created page Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Reference |Reference=Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were divided into two different arms before radiotherapy. One arm received additional vitamin E throughout the radiotherapy and the other arm only a placebo. There were significantly fewer cases of oral mucositis (i.e. inflammation...")
12:10, 5 July 2024 JDoerfler talk contribs created page Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Publication |Title=Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial |Topic=Vitamin E |Author=Ferreira, PR; Fleck, JF; Diehl, A; Barletta, D; Braga-Filho, A; Barletta, A; Ilha, L |Year=2004 |Journal=Head and Neck |DOI=https://10.1002/hed.10382 |Authors Abstract=Abstract: Background. The study was designed to test whether vitamin E (VE) provides oral mucosal protection in patients with irradiated c...")
11:29, 5 July 2024 JDoerfler talk contribs created page Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Reference |Reference=Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on an...")
11:21, 5 July 2024 JDoerfler talk contribs created page Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Publication |Title=Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? |Topic=Vitamin E |Author=Fallahi, B; Beiki, D; Abedi, SM; Saghari, M; Fard-Esfahani, A; Akhzari, F; Mokarami, B; Eftekhari, M |Year=2013 |Journal=Nuclear medicine communications |DOI=https://10.1097/MNM.0b013e328362b1f2 |Authors Abstract=Objectives Salivary gland impairment after high-dose radioiodine (131I) treatment is well recognized. The aim of thi...")
09:22, 5 July 2024 JDoerfler talk contribs created page Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Reference |Reference=Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-9...")
09:21, 5 July 2024 JDoerfler talk contribs created page Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Publication |Title=Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis |Topic=Vitamin E |Author=Delanian, S; Porcher, R; Balla-Mekias, S; Lefaix, J-L |Year=2003 |Journal=Journal of clinical Oncology |DOI=https://10.1200/JCO.2003.06.064 |Authors Abstract=Purpose: Radiation-induced fibrosis (RIF) is a rare morbid complication of radiotherapy, without an established method of management. R...")
14:27, 4 July 2024 JDoerfler talk contribs created page Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Reference |Reference=Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries o...")
14:26, 4 July 2024 JDoerfler talk contribs created page Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Publication |Title=Prospective evaluation of vitamin E for hot flashes in breast cancer survivors |Topic=Vitamin E |Author=Barton, DL; Loprinzi, CL; Quella, SK; Sloan, JA; Veeder, MH; Egner, JR; Fidler, P; Stella, PJ; Swan, DK; Vaught, NL; Novotny, P |Year=1998 |Journal=Journal of clinical Oncology |DOI=https://doi.org/10.1200/JCO.1998.16.2.495 |Authors Abstract=Purpose Hot flashes are a significant issue for many breast cancer survivors, with concerns over the use of...")
14:18, 4 July 2024 JDoerfler talk contribs created page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specificat...")
14:17, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://10.1093/jnci/dji095 |Authors Abstract=Background: Although low dietary intakes of an...")
13:37, 4 July 2024 JDoerfler talk contribs created page Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Reference |Reference=Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=...")
13:37, 4 July 2024 JDoerfler talk contribs created page Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Publication |Title=Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis |Topic=Vitamin E |Author=Azizi, A; Alirezaei, S; Pedram, P; Mafi, AR |Year=2015 |Journal=Reports of Radiotherapy and Oncology |DOI=https://0.5812/rro.2(1)2015.796 |Authors Abstract=Background: There is still no consensus regarding the optimum treatment of chemotherapy-induced oral mucositis, and its management is still mainly supportive. Vitamin E has been sh...")
13:09, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Reference |Reference=Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |E...")
13:08, 4 July 2024 JDoerfler talk contribs created page Publication: Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Publication |Title=Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Journal of Pain and Symptom Management |DOI=https://10.1016/j.jpainsymman.2006.03.013 |Authors Abstract=A randomized, controlled trial was performed to assess the efficacy and safety of vitamin E supplement...")
11:30, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Cha...")
11:29, 4 July 2024 JDoerfler talk contribs deleted page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (content was: "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI...", and the only contributor was "JDoerfler" (talk))
11:29, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
11:26, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
13:16, 1 July 2024 JDoerfler talk contribs deleted page Pubclivation: TItel STudie (content was: "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}", and the only contributor was "JDoerfler" (talk))
13:16, 1 July 2024 JDoerfler talk contribs deleted page Syrh (content was: "{{Reference |Reference=Pubclivation: TItel STudie }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Coun...", and the only contributor was "JDoerfler" (talk))
13:08, 1 July 2024 JDoerfler talk contribs created page Pubclivation: TItel STudie (Created page with "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}")
13:04, 1 July 2024 JDoerfler talk contribs created page Syrh (Created page with "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Characteristics of participants |...")
12:20, 25 June 2024 JDoerfler talk contribs created page Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Reference |Reference=Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of da...")
12:19, 25 June 2024 JDoerfler talk contribs created page Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Publication |Title=Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial |Topic=Vitamin E |Author=Afonseca, SOd; Cruz, FM; Cubero, DDdlG; Lera, AT; Schindler, F; Okawara, M; Souza, LFd; Rodrigues, NP; Giglio, Ad |Year=2013 |Journal=Sao Paulo Medical Journal |DOI=https://doi.org/10.1590/S1516-31802013000100006 |Authors Abstract=CONTEXT AND OBJECTIVE Oxaliplatin is one of the chemotherapy regimens most used for treating...")
08:03, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumours Laboratory data from two observation studies in gynaecological and head and neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analys...")
08:02, 25 June 2024 JDoerfler talk contribs deleted page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (content was: "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |An...", and the only contributor was "JDoerfler" (talk))
08:00, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =...")
11:57, 17 June 2024 JDoerfler talk contribs created page Publication: Selenium Substitution During Radiotherapy of Solid Tumours Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients (Created page with "{{Publication |Title=Selenium Substitution During Radiotherapy of Solid Tumours Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients |Topic=Selenium |Author=Büntzel, J; Micke, O; Kisters, K; Bruns, F; Glatzel, M; Schänekaes, K; Kundt, C; Schäfer, U; Mücke, R |Year=2010 |Journal=Anticancer Research |DOI=https://ar.iiarjournals.org/content/30/5/1783.short |Authors Abstract=Objective: Selenium is an essential cofactor of the e...")
12:43, 14 June 2024 JDoerfler talk contribs created page Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusio...")
12:42, 14 June 2024 JDoerfler talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization |Topic=Selenium |Author=Muecke, R; Micke, O; Schomburg, L; Glatzel, M; Reichl, B; Kisters, K; Schaefer, U; Huebner, J; Eich, HT; Fakhrian, K; Adamietz, IA; Buentzel, J |Year=2014 |Journal=Integrative Cancer Therapies |DOI=10.1177/1534735414541963 |Authors Abs...")
12:14, 14 June 2024 JDoerfler talk contribs created page Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial (Created page with "{{Reference |Reference=Publication: Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion crite...")
12:11, 14 June 2024 JDoerfler talk contribs created page Publication: Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial (Created page with "{{Publication |Title=Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial |Topic=Selenium |Author=Muecke, R; Micke, O; Schomburg, L; Buentzel, J; Glatzel, M; Baaske, D; Berndt-Skorka, R; Prott, FJ; Reichl, B; Kisters, K; Schaefer, U; Huebner, J; Eich, HT; Kundt, G; Adamietz, IA |Year=2013 |Journal=Radiation Oncology...")
07:52, 13 June 2024 JDoerfler talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countri...")